Community-Acquired Infections Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
- Visit
Mulholland S, Gavranich JB, Gillies MB, Chang AB
Mulholland S, Gavranich JB, Gillies MB, Chang AB
OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.
OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.
Cochrane Systematic Review: Antibiotics for community-acquired pneumonia in children
Cochrane Systematic Review: Antibiotics for community-acquired pneumonia in children
- Visit
Lodha R, Kabra SK, Pandey RM
Lodha R, Kabra SK, Pandey RM
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
- Visit
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002109. do...
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumon...
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
- Visit
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Cochrane Systematic Review: Osmotic therapies added to antibiotics for bacterial meningitis
Cochrane Systematic Review: Osmotic therapies added to antibiotics for bacterial meningitis
- Visit
Wall EC, Ajdukiewicz KM, Heyderman RS, Garner P.
Wall EC, Ajdukiewicz KM, Heyderman RS, Garner P.
Objectives: To evaluate the effects on mortality, deafness and neurological disability of osmotic therapies added to antibiotics for bacterial meningitis in children and adults.
Objectives: To evaluate the effects on mortality, deafness and neurological disability of osmotic therapies added to antibiotics for bacterial meningitis in children and adults.
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
- Visit
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
- Visit
Hemil H, Louhiala P.
Hemil H, Louhiala P.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
- Visit
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
- Visit
Mulholland S, Gavranich JB, Gillies MB, Chang AB
Mulholland S, Gavranich JB, Gillies MB, Chang AB
OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.
OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.
Cochrane Systematic Review: Antibiotics for community-acquired pneumonia in children
Cochrane Systematic Review: Antibiotics for community-acquired pneumonia in children
- Visit
Lodha R, Kabra SK, Pandey RM
Lodha R, Kabra SK, Pandey RM
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
- Visit
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002109. do...
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumon...
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
- Visit
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Cochrane Systematic Review: Osmotic therapies added to antibiotics for bacterial meningitis
Cochrane Systematic Review: Osmotic therapies added to antibiotics for bacterial meningitis
- Visit
Wall EC, Ajdukiewicz KM, Heyderman RS, Garner P.
Wall EC, Ajdukiewicz KM, Heyderman RS, Garner P.
Objectives: To evaluate the effects on mortality, deafness and neurological disability of osmotic therapies added to antibiotics for bacterial meningitis in children and adults.
Objectives: To evaluate the effects on mortality, deafness and neurological disability of osmotic therapies added to antibiotics for bacterial meningitis in children and adults.
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
- Visit
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
- Visit
Hemil H, Louhiala P.
Hemil H, Louhiala P.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
- Visit
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
